Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
1.670
-0.140 (-7.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $5.01 million as of December 20, 2024. Its market cap has decreased by -67.86% in one year.
Market Cap
5.01M
Enterprise Value
-3.89M
1-Year Change
-67.86%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $5.01M, a decrease of -92.91%. That is a compound annual growth rate of -26.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 5.00M | -80.47% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SunLink Health Systems | 5.44M |
| Bio-Path Holdings | 5.43M |
| Syros Pharmaceuticals | 5.37M |
| Evaxion Biotech | 5.13M |
| Polyrizon | 5.08M |
| FOXO Technologies | 4.91M |
| Clearmind Medicine | 4.87M |
| NuCana | 4.75M |